共 50 条
- [21] One-year Maintenance of Efficacy and Safety of Desvenlafaxine in Women With Vasomotor Symptoms Associated With Menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (12): : 1367 - 1367
- [23] Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (05): : 553 - 563
- [24] Is placebo as effective as estrogen regimens on vasomotor symptoms in women with surgical menopause? CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2010, 37 (02): : 135 - 137
- [26] Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (01): : 50 - 58
- [27] Cardiovascular, Cerebrovascular and Hepatic Safety of Desvenlafaxine Over 1 Year in Women With Vasomotor Symptoms Associated With Menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (12): : 1348 - 1348
- [30] Effect of Body Mass Index on Treatment of Vasomotor Symptoms Associated with Menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1211 - 1212